GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (FRA:ABG) » Definitions » Cyclically Adjusted Revenue per Share

Cencora (FRA:ABG) Cyclically Adjusted Revenue per Share : €960.73 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Cencora Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cencora's adjusted revenue per share for the three months ended in Mar. 2024 was €312.865. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €960.73 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Cencora's average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 15.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cencora was 16.90% per year. The lowest was 13.00% per year. And the median was 15.10% per year.

As of today (2024-05-18), Cencora's current stock price is €202.20. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €960.73. Cencora's Cyclically Adjusted PS Ratio of today is 0.21.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.39. The lowest was 0.14. And the median was 0.19.


Cencora Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Cencora's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Cyclically Adjusted Revenue per Share Chart

Cencora Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 517.02 537.92 650.82 918.16 942.19

Cencora Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 842.87 867.98 942.19 892.48 960.73

Competitive Comparison of Cencora's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.



Cencora Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cencora's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=312.865/131.7762*131.7762
=312.865

Current CPI (Mar. 2024) = 131.7762.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 98.952 100.560 129.670
201409 104.299 100.428 136.856
201412 124.127 99.070 165.106
201503 137.060 99.621 181.299
201506 126.967 100.684 166.176
201509 149.022 100.392 195.610
201512 148.638 99.792 196.277
201603 142.192 100.470 186.498
201606 146.016 101.688 189.220
201609 147.496 101.861 190.814
201612 163.008 101.863 210.878
201703 157.005 102.862 201.138
201706 155.266 103.349 197.973
201709 148.304 104.136 187.668
201712 154.849 104.011 196.185
201803 149.699 105.290 187.357
201806 167.285 106.317 207.344
201809 170.638 106.507 211.123
201812 186.475 105.998 231.825
201903 180.360 107.251 221.604
201906 189.603 108.070 231.195
201909 193.725 108.329 235.655
201912 207.589 108.420 252.308
202003 207.247 108.902 250.779
202006 195.995 108.767 237.456
202009 204.864 109.815 245.834
202012 208.745 109.897 250.304
202103 199.163 111.754 234.845
202106 212.179 114.631 243.913
202109 237.524 115.734 270.447
202112 249.903 117.630 279.958
202203 247.224 121.301 268.574
202206 268.356 125.017 282.865
202209 294.301 125.227 309.694
202212 287.541 125.222 302.592
202303 290.170 127.348 300.260
202306 302.347 128.729 309.505
202309 317.536 129.860 322.223
202312 328.264 129.419 334.242
202403 312.865 131.776 312.865

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Cencora  (FRA:ABG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=202.20/960.73
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.39. The lowest was 0.14. And the median was 0.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cencora Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cencora's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora (FRA:ABG) Business Description

Industry
Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.